✦ LIBER ✦

Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

✍ Scribed by Gordon C. Jayson; Clive Mulatero; Malcolm Ranson; Jamal Zweit; Alan Jackson; Lynn Broughton; John Wagstaff; Leif Hakansson; Gerard Groenewegen; Jeremy Lawrance; Meina Tang; Linda Wauk; Dan Levitt; Sandrine Marreaud; Frederic F. Lehmann; Manfred Herold; Heinz Zwierzina

Book ID: 116428433
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 215 KB
Volume: 41
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2004.11.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I safety, pharmacokinetic and phar

Phase I safety, pharmacokinetic and pharmacodynamic study of recombinant human anti-VEGF antibody HuMV833 in patients with advanced cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Phase I clinical trial using peptide vac

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

✍ Motoki Miyazawa; Ryuji Ohsawa; Takuya Tsunoda; Seiko Hirono; Manabu Kawai; Masaj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

A Phase II Trial of Humanized Anti-Vascu

A Phase II Trial of Humanized Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Androgen-Independent Prostate Cancer

✍ David M. Reese; Paige Fratesi; Michelle Corry; William Novotny; Eric Holmgren; E 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

647 POSTER A phase I dose-escalation stu

647 POSTER A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase II study of nimotuzumab, a humaniz

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

A phase-I trial of the epidermal growth

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

✍ Matthew G. Fury; Allan Lipton; Katherine M. Smith; Corinne B. Winston; David G. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 377 KB